Replimune: Reducing Site and Patient Burden
Replimune, a Woburn, Massachusetts biotech, faced heavy clinical trial data-management burden on sites and patients. It implemented Veeva EDC and Veeva DQS along with other trial operations tools to reduce that burden. The page states the result was a '30% reduction in data entry for sites' and approximately '$1M monitoring costs saved per trial.' These figures are presented as the concrete outcome of the implementation.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment